HeartBeam, Inc. received a deficiency letter from Nasdaq notifying the company's common stock has failed to meet the minimum $1.00 bid price requirement for continued listing on the Nasdaq Capital Market. The company has a 180-day compliance period ending December 28, 2026, to regain compliance by maintaining a $1.00 closing bid price for ten consecutive business days. HeartBeam, Inc. is a medical technology company that develops non-invasive optical sensor technology for heart rate and heart rate variability monitoring.
